Details of the Drug
General Information of Drug (ID: DM1AVCZ)
Drug Name |
N-oleoyl-dopamine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
N-Oleoyldopamine; OLDA; N-Oleoyl dopamine; N-oleoyl-dopamine; 105955-11-1; OLEOYL DOPAMINE; UNII-T87P7X9XSZ; T87P7X9XSZ; N-[2-(3,4-dihydroxyphenyl)ethyl]-9Z-octadecenamide; CHEMBL250711; CHEBI:31883; (Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]octadec-9-enamide; SR-01000076132; AC1NQZHH; Lopac-O-2139; Lopac0_001058; SCHEMBL93916; MLS002153451; N-(9Z-octadecanoyl)-dopamine; GTPL5552; BML3-G02; cid_5282106; (9Z)- N-(2-(3,4-Dihydroxyphenyl)ethyl)-9-octadecenamide; MolPort-003-959-070; QQBPLXNESPTPNU-KTKRTIGZSA-N; HMS3648E03; HMS3263C18
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 2 | Molecular Weight (mw) | 417.6 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 8.3 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 18 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 3 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Off-Target (DOT) |
|
||||||||||||||||||||||||||
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References